Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Cameron

Showing results (1491-1500 of 1,773) with videos related to

Pageof 178
Sort By:
Spinal Cord|July 6, 2023
Early and intensive motor training to enhance neurological recovery in people with spinal cord injury: trial protocolLisa A Harvey, Joanne V Glinsky, Jackie Chu, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|August 8, 2015
Inverse relationship between body mass index and mortality in older nursing home residents: a meta-analysis of 19,538 elderly subjectsN Veronese, E Cereda, M Solmi, et al.
The Lancet. Neurology|February 21, 2026
Safety and efficacy of intensive task-specific training in people with recent spinal cord injury: a phase 3, pragmatic, randomised, assessor-blinded, superiority trialJoanne V Glinsky, Jackie Chu, Christine Rimmer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2025
Palbociclib with adjuvant endocrine therapy in early breast cancer: 5-year follow-up analysis of the global multicenter, open-label, randomized phase III PALLAS trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13)E L Mayer, D Hlauschek, M Gnant, et al.
ESMO Open|October 17, 2024
Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)]E de Azambuja, M Piccart-Gebhart, S Fielding, et al.
ESMO Open|June 5, 2025
Quality-of-life and symptom severity in the PALLAS randomized trial of palbociclib with adjuvant endocrine therapy in early breast cancer (AFT-05, ABCSG-42, BIG-14-03, PrE0109)M J Naughton, D M Zahrieh, M Gnant, et al.
Nature Genetics|November 16, 2002
HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndromeJ D Carpten, C M Robbins, A Villablanca, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 2015
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†S Gourgou-Bourgade, D Cameron, P Poortmans, et al.
Nature|March 20, 2012
A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic responseZhao Chen, Katherine Cheng, Zandra Walton, et al.
Age and Ageing|September 30, 2022
World guidelines for falls prevention and management for older adults: a global initiativeManuel Montero-Odasso, Nathalie van der Velde, Finbarr C Martin, et al.
Pageof 178

Showing results (1491-1500 of 1,773) with videos related to

Sort By:
Pageof 178
Spinal Cord|July 6, 2023
Early and intensive motor training to enhance neurological recovery in people with spinal cord injury: trial protocolLisa A Harvey, Joanne V Glinsky, Jackie Chu, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|August 8, 2015
Inverse relationship between body mass index and mortality in older nursing home residents: a meta-analysis of 19,538 elderly subjectsN Veronese, E Cereda, M Solmi, et al.
The Lancet. Neurology|February 21, 2026
Safety and efficacy of intensive task-specific training in people with recent spinal cord injury: a phase 3, pragmatic, randomised, assessor-blinded, superiority trialJoanne V Glinsky, Jackie Chu, Christine Rimmer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2025
Palbociclib with adjuvant endocrine therapy in early breast cancer: 5-year follow-up analysis of the global multicenter, open-label, randomized phase III PALLAS trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13)E L Mayer, D Hlauschek, M Gnant, et al.
ESMO Open|October 17, 2024
Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)]E de Azambuja, M Piccart-Gebhart, S Fielding, et al.
ESMO Open|June 5, 2025
Quality-of-life and symptom severity in the PALLAS randomized trial of palbociclib with adjuvant endocrine therapy in early breast cancer (AFT-05, ABCSG-42, BIG-14-03, PrE0109)M J Naughton, D M Zahrieh, M Gnant, et al.
Nature Genetics|November 16, 2002
HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndromeJ D Carpten, C M Robbins, A Villablanca, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 2015
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†S Gourgou-Bourgade, D Cameron, P Poortmans, et al.
Nature|March 20, 2012
A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic responseZhao Chen, Katherine Cheng, Zandra Walton, et al.
Age and Ageing|September 30, 2022
World guidelines for falls prevention and management for older adults: a global initiativeManuel Montero-Odasso, Nathalie van der Velde, Finbarr C Martin, et al.
Pageof 178